IFNG and triple-negative breast carcinoma: This study presents a comprehensive bioinformatics-based investigation into the ferroptosis landscape of triple-negative breast cancer (TNBC), with a central focus on the role of interferon-gamma (IFNG) as a potential prognostic marker and modulator of ferroptotic signaling.